Dr. Erik N Cohen, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 18181 Butterfield Blvd, Suite 125, Morgan Hill, CA 95037 Phone: 408-779-9992 Fax: 408-779-6599 |
News Archive
The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma, according to results from a Phase I trial simultaneously published online on Sunday, June 2, in The New England Journal of Medicine and presented by Memorial Sloan-Kettering Cancer Center researchers at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).
Human papillomavirus (HPV) can infect the mouth and throat to cause cancers of the oropharynx. A new study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, has found that having more than 10 prior oral sex partners was associated with a 4.3-times greater likelihood of having HPV-related oropharyngeal cancer.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it presented new pre-clinical research findings from its transthyretin (TTR)-mediated amyloidosis (ATTR) program at the 60th Annual Meeting of the American Association for the Study of Liver Diseases ("The Liver Meeting").
A team of Genographic researchers and their collaborators have published the most extensive survey to date of African mitochondrial DNA (mtDNA).
› Verified 1 days ago